索引超出了数组界限。
[1] Guo C, Zhao Z, Deng X, et al. Regulation of angiopoietin-like
protein 8 expression under different nutritional and metabolic
status[J]. Endocr J, 2019, 66(12):1039-1046.
[2] Alenad A, Alenezi MM, Alokail MS, et al. Association of
ANGPTL8 (betatrophin) gene variants with components of
metabolic syndrome in Arab adults[J]. Sci Rep, 2020, 10(1):6764.
[3] Ghasemi H, Karimi J, Khodadadi I, et al. Association between
rs2278426 (C/T) and rs892066 (C/G) variants of ANGPTL8
(betatrophin) and susceptibility to type2 diabetes mellitus[J]. J
Clin Lab Anal, 2019, 33(1):e22649.
[4] Watanabe T, Ozawa A, Masuda S, et al. Transcriptional
regulation of the angptl8 gene by hepatocyte nuclear factor-1
in the murine liver[J]. Sci Rep, 2020, 10(1):9999.
[5] Quagliarini F, Wang Y, Kozlitina J, et al. Atypical angiopoietinlike
protein that regulates ANGPTL3[J]. Proc Natl Acad Sci U
S A, 2012, 109(48):19751-19756.
[6] Morelli MB, Chavez C, Santulli G. Angiopoietin-like proteins
as therapeutic targets for cardiovascular disease: focus on lipid
disorders[J]. Expert Opin Ther Targets, 2020, 24(1):79-88.
[7] 申晓平,魏依兰,窦志杰,等.循环血管生成素样蛋白8
在糖脂代谢方面最新研究进展[J].中华老年心脑血管病杂
志,2019,21(11):1220-1222.
[8] Fu W, Chen N, Han S, et al. Tissue expression and variation
analysis of three bovine adipokine genes revealed their effect
on growth traits in native Chinese cattle[J]. Reprod Domest
Anim, 2018, 53(5):1227-1234.
[9] Liu HH, Cao YX, Sun D, et al. High-sensitivity C-reactive
protein and hypertension:combined effects on coronary
severity and cardiovascular outcomes[J]. Hypertens Res, 2019,
42(11):1783-1793.
[10] Fadaei R, Shateri H, Distefano JK, et al. Higher circulating
levels of ANGPTL8 are associated with body mass index,
triglycerides, and endothelial dysfunction in patients with
coronary artery disease[J]. Mol Cell Biochem, 2020, 469(1/2):
29-39.
[11] Abu-Farha M, Cherian P, Qaddoumi MG, et al. Increased
plasma and adipose tissue levels of ANGPTL8/Betatrophin
and ANGPTL4 in people with hypertension[J]. Lipids Health
Dis, 2018, 17(1):35.
[12] 谢林涧,李骊华.血管内皮生长因子在心血管疾病中的作
用[J].国际心血管病杂志,2019,46(4):219-222.
[13] Gómez-Ambrosi J, Pascual-Corrales E, Catalán V, et al.
Altered concentrations in dyslipidemia evidence a role for
ANGPTL8/betatrophin in lipid metabolism in humans[J]. J
Clin Endocrinol Metab, 2016, 101(10):3803-3811.
[14] Zhang Y, Guo X, Yan W, et al. ANGPTL8 negatively regulates
NF-κB activation by facilitating selective autophagic
degradation of IKKγ[J]. Nat Commun, 2017, 8(1):2164.
[15] Zhang Z, Wu H, Dai L, et al. ANGPTL8 enhances insulin
sensitivity by directly activating insulin-mediated AKT
phosphorylation[J]. Gene, 2020, 749:144707.
[16] Guo XR, Wang XL, Chen Y, et al. ANGPTL8/betatrophin
alleviates insulin resistance via the Akt-GSK3β or Akt-FoxO1
pathway in HepG2 cells[J]. Exp Cell Res, 2016, 345(2):158-
167.
[17] Huang Z, Chen C, Li S, et al. Serum markers of endothelial
dysfunction and inflammation increase in hypertension with
prediabetes mellitus[J]. Genet Test Mol Biomarkers, 2016,
20(6):322-327.
[18] Jiao X, Yang Y, Li L, et al. Angiopoietin-like protein 8
accelerates atherosclerosis in ApoE-/-mice[J]. Atherosclerosis,
2020, 307:63-71.
[19] DiStefano JK. Angiopoietin-like 8 (ANGPTL8) expression
is regulated by miR-143-3p in human hepatocytes[J]. Gene,
2019, 681:1-6.
[20] Tseng YH, Ke PY, Liao CJ, et al. Chromosome 19 open
reading frame 80 is upregulated by thyroid hormone and
modulates autophagy and lipid metabolism[J]. Autophagy,
2014, 10(1):20-31.
[21] Vatner DF, Goedeke L, Camporez JG, et al. Angptl8 antisense
oligonucleotide improves adipose lipid metabolism and
prevents diet-induced NAFLD and hepatic insulin resistance
in rodents[J]. Diabetologia, 2018, 61(6):1435-1446.
[22] Yang S, Jiao X, Huo X, et al. Association between circulating
full-length angiopoietin-like protein 8 and non-high-density
lipoprotein cholesterol levels in Chinese non-diabetic
individuals: a cross-sectional study[J]. Lipids Health Dis,
2018, 17(1):161.
[23] Li Y, Teng C. Angiopoietin-like proteins 3, 4 and 8: regulating
lipid metabolism and providing new hope for metabolic
syndrome[J]. J Drug Target, 2014, 22(8):679-687.